3,4-Dichlorobenzotrifluoride Pharmaceutical Grade from Japan
Pharmaceutical-grade 3,4-Dichlorobenzotrifluoride with <10ppm heavy metals, used in synthesis of anti-cancer drug intermediates. Meets HTS 2903.99.08.00 as explicitly named halogenated aromatic hydrocarbon under chapter 29 pure compound provisions.
Duty Rate — Japan → United States
15.5%
Rate breakdown
9903.03.0110%Except for products described in headings 9903.03.02–9903.03.11, articles the product of any country, as provided for in subdivision (aa) of U.S. note 2 to this subchapter
Import Tips
• Provide Certificate of Analysis (CoA) with ICH Q3D elemental impurities testing results
• Declare under FDA prior notice if destined for US pharmaceutical manufacturing
• Use EP/USP stabilizer-free packaging to maintain chapter 29 classification